Next Quarterly Earnings
Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Xeris Biopharma Holdings
Xeris Biopharma Holdings is a US-based biopharmaceutical company that develops and markets innovative therapeutic solutions for rare endocrine diseases and diabetes. The company focuses on providing ready-to-use injectable solutions to improve patient care and simplify therapy. Their medications target unmet medical needs.
Frequently asked questions
When will Xeris Biopharma Holdings report its next quarterly earnings?
Xeris Biopharma Holdings is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Xeris Biopharma Holdings last report quarterly earnings?
Xeris Biopharma Holdings last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.18 USD.
How does Xeris Biopharma Holdings stock react to earnings?
Across its last 3 earnings reports, Xeris Biopharma Holdings stock moved by ±9.2% on average the following day. The largest reaction was -21.9% on 11/06/2025; 1 of 3 reactions were positive.
How often has Xeris Biopharma Holdings beaten expectations?
Xeris Biopharma Holdings has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
How do I add the Xeris Biopharma Holdings earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±9.2%
Avg. next-day move
-21.9%
Largest move (11/06/2025)
33.3%
Share of positive reactions
±11.7%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
3/5
Quarters above estimates
60%
Beat rate
-185.4%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Xeris Biopharma Holdings
Country
🇺🇸
More Financial Information